ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 208885 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 208885; 2) Community: the network communities that were significantly associated with the response to NSC 208885; 3) Molecule: the relationships between components within communities and NSC 208885; 4) MDR: the compounds that were significantly associated with the NSC 208885.

NSC Compound Enrichment Correlation
NSC 120925 Null 0.0478540623811426 0.42051067
NSC 13275 Null 0.0478540623811426 0.37874191
NSC 132791 Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo 0.0478540623811426 0.50499642
NSC 295272 Null 0.0478540623811426 -0.16779958
NSC 330507 Tanespimycin 0.0478540623811426 0.31391013
NSC 346098 Null 0.0478540623811426 0.62527442
NSC 55720 Phosphinic acid, bis(1-aziridinyl)-, 2-naphthalenyl ester (9CI) 0.0478540623811426 -0.13086436
NSC 58573 Pyrimidine, 2,4,5-trichloro-6-ethyl- 0.0478540623811426 -0.027909882
NSC 608984 Leucinostatine D 0.0478540623811426 0.60912118
NSC 616362 2-Methoxycarbonyl-3,4-dichloro-5-nitrofuran 0.0478540623811426 0.12330287
Total:135  Current:127    [First] [Prev] [Next] [Last]